4.8 Article

Pharmit: interactive exploration of chemical space

Journal

NUCLEIC ACIDS RESEARCH
Volume 44, Issue W1, Pages W442-W448

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw287

Keywords

-

Funding

  1. National Institute of General Medical Sciences [R01GM108340]

Ask authors/readers for more resources

Pharmit (http://pharmit.csb.pitt.edu) provides an online, interactive environment for the virtual screening of large compound databases using pharmacophores, molecular shape and energy minimization. Users can import, create and edit virtual screening queries in an interactive browser-based interface. Queries are specified in terms of a pharmacophore, a spatial arrangement of the essential features of an interaction, and molecular shape. Search results can be further ranked and filtered using energy minimization. In addition to a number of pre-built databases of popular compound libraries, users may submit their own compound libraries for screening. Pharmit uses state-of-the-art sub-linear algorithms to provide interactive screening of millions of compounds. Queries typically take a few seconds to a few minutes depending on their complexity. This allows users to iteratively refine their search during a single session. The easy access to large chemical datasets provided by Pharmit simplifies and accelerates structure-based drug design. Pharmit is available under a dual BSD/GPL open-source license.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

libmolgrid: Graphics Processing Unit Accelerated Molecular Gridding for Deep Learning Applications

Jocelyn Sunseri, David R. Koes

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)

Meeting Abstract Biochemistry & Molecular Biology

Identifying Best Target Pocket for Small Molecule Inhibition of Beta Catenin/E-Cadherin Binding

Faiha Khan, Di Zhang, David Koes

FASEB JOURNAL (2020)

Article Biochemistry & Molecular Biology

Disruption of profilin1 function suppresses developmental and pathological retinal neovascularization

David Gau, Lucile Vignaud, Abigail Allen, Zhijian Guo, Jose Sahel, David Boone, David Koes, Xavier Guillonneau, Partha Roy

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Article Chemistry, Physical

Evaluation of Thermochemical Machine Learning for Potential Energy Curves and Geometry Optimization

Dakota L. Folmsbee, David R. Koes, Geoffrey R. Hutchison

Summary: The study evaluates the accuracy of several mainstream machine learning methods and finds that some of them offer qualitative and quantitative accuracy on small molecules, such as correct minima and mean absolute percent error. ANI-2x, FCHL, and a new libmolgrid-based convolutional neural net, the Colorful CNN, show good performance.

JOURNAL OF PHYSICAL CHEMISTRY A (2021)

Correction Chemistry, Medicinal

SolTranNet-A Machine Learning Tool for Fast Aqueous Solubility Prediction (vol 61, pg 2530, 2021)

Paul G. Francoeur, David R. Koes

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Chemistry, Medicinal

SolTranNet-A Machine Learning Tool for Fast Aqueous Solubility Prediction

Paul G. Francoeur, David R. Koes

Summary: SolTranNet is a machine learning model for predicting aqueous solubility based on a molecule's SMILES representation. Contrary to previous assumptions, the study found that larger models do not necessarily perform better, with SolTranNet outperforming linear ML approaches. The model shows promising results and competitive performance when used to filter out insoluble compounds.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)

Article Biochemistry & Molecular Biology

SidechainNet: An all-atom protein structure dataset for machine learning

Jonathan Edward King, David Ryan Koes

Summary: This article introduces a new dataset, SidechainNet, which extends ProteinNet and includes angle and atomic coordinate information for protein structures. By incorporating sidechain information, SidechainNet can describe all heavy atoms, and users can extend it to include new protein structures.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2021)

Article Chemistry, Multidisciplinary

GNINA 1.0: molecular docking with deep learning

Andrew T. McNutt, Paul Francoeur, Rishal Aggarwal, Tomohide Masuda, Rocco Meli, Matthew Ragoza, Jocelyn Sunseri, David Ryan Koes

Summary: Molecular docking software Gnina 1.0, utilizing convolutional neural networks as scoring functions, outperforms AutoDock Vina in redocking and cross-docking tasks when binding pockets are explicitly defined. The ensemble of CNNs shows good generalization to unseen proteins and ligands, producing scores that correlate well with known binding poses. The 1.0 version of GNINA is available under an open source license for use as a molecular docking tool.

JOURNAL OF CHEMINFORMATICS (2021)

Article Ophthalmology

Inhibition of ocular neovascularization by novel anti-angiogenic compound

David Gau, Lucile Vignaud, Paul Francoeur, David Koes, Xavier Guillonneau, Partha Roy

Summary: Aberrant angiogenesis is at the core of many ocular pathologies, and this study focuses on a novel small molecule compound that has antiangiogenic activity by inhibiting profilin1-actin interaction. The compound was found to inhibit migration, proliferation, and angiogenic activity of microvascular endothelial cells in vitro, as well as choroidal neovascularization ex vivo. Preliminary structure-activity relationship study showed potential for improving biological activity through structural modifications.

EXPERIMENTAL EYE RESEARCH (2021)

Article Biochemistry & Molecular Biology

Virtual Screening with Gnina 1.0

Jocelyn Sunseri, David Ryan Koes

Summary: Virtual screening is important in drug discovery, but there are inherent tradeoffs between accuracy and speed in the algorithms used. The Gnina molecular docking software outperforms conventional empirical scoring in virtual screening, but bias issues still exist.

MOLECULES (2021)

Article Chemistry, Multidisciplinary

Generating 3D molecules conditional on receptor binding sites with deep generative models

Matthew Ragoza, Tomohide Masuda, David Ryan Koes

Summary: This study presents a deep learning system for generating 3D molecular structures conditioned on a receptor binding site, using an atomic density grid representation to train a conditional variational autoencoder. The properties of the generated molecules are evaluated, showing significant changes under different conditions such as mutated receptors. Sampling and interpolation techniques are used to explore the latent space learned by the generative model, allowing for end-to-end prediction of stable bioactive molecules from protein structures with deep learning.

CHEMICAL SCIENCE (2022)

Article Chemistry, Medicinal

Improving ΔΔG Predictions with a Multitask Convolutional Siamese Network

Andrew T. McNutt, David Ryan Koes

Summary: In this study, a Siamese convolutional neural network (CNN) is proposed for the prediction of relative binding free energy (RBFE) between two bound ligands. The network shows improved performance in RBFE prediction compared to a standard CNN, and its predictive performance varies among different protein families. Additionally, the RBFE prediction performance can be enhanced through few-shot learning during model training.

JOURNAL OF CHEMICAL INFORMATION AND MODELING (2022)

Article Chemistry, Multidisciplinary

DeepFrag: a deep convolutional neural network for fragment-based lead optimization

Harrison Green, David R. Koes, Jacob D. Durrant

Summary: Machine learning has been increasingly applied in the field of computer-aided drug discovery, showing notable advances in binding-affinity prediction, virtual screening, and QSAR. A deep convolutional neural network was used to predict appropriate fragments based on the structure of a receptor/ligand complex, with an efficiency of about 58% in selecting correct fragments from known ligands. The trained DeepFrag model and its associated software have been released under the Apache License, Version 2.0.

CHEMICAL SCIENCE (2021)

Article Medicine, Research & Experimental

Assessing acquired resistance to IDH1 inhibitor therapy by full-exon IDH1 sequencing and structural modeling

Zoltan N. Oltvai, Susan E. Harley, David Koes, Stephen Michel, Erica D. Warlick, Andrew C. Nelson, Sophia Yohe, Pawel Mroz

Summary: This study describes the development of drug resistance in an AML patient treated with the IDH1 inhibitor ivosidenib. Monitoring for acquired drug resistance through full-exon NGS and structural modeling can help in choosing follow-up therapy for IDH1 inhibitor-treated AML patients.

COLD SPRING HARBOR MOLECULAR CASE STUDIES (2021)

No Data Available